Implementation of Fuzzy-based Model for Prediction of Prostate Cancer

Cancer is one of the leading causes of death worldwide. One type of cancer that causes death in the male population is prostate cancer. This disease occurs only in men because in women they do not have a prostate appearance. The aim of this study was to compare the accuracy of the model with the pre...

Full description

Saved in:
Bibliographic Details
Published in:Journal of physics. Conference series 2021-01, Vol.1751 (1), p.12041
Main Authors: Rusliyawati, Muludi, Kurnia, Syarif, Admi, Wantoro, Agus
Format: Article
Language:English
Subjects:
age
and prostate cancer risk
Antigens
Dependent variables
fuzzy expert system
Independent variables
Men
Model accuracy
Model testing
patient prostate volume
Physicians
Physics
Prostate cancer
prostate specific antigen
Risk levels
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cancer is one of the leading causes of death worldwide. One type of cancer that causes death in the male population is prostate cancer. This disease occurs only in men because in women they do not have a prostate appearance. The aim of this study was to compare the accuracy of the model with the predictions of prostate cancer specialists. Prediction is made based on prostate specific antigen data, age, and patient prostate volume. The independent variables in this study were prostate specific antigen, age, and prostate volume. The dependent variable is the risk of prostate cancer using a fuzzy model. The novelty of this study is that the model has a low, moderate, high, and very high prostate cancer risk level output. In the previous article only PCR values were produced. The results show that the proposed fuzzy model provides a PCR value that is within the PCR interval predicted by a specialist doctor can be used properly to help diagnose and analyze the possibility of prostate cancer and is one of the considerations for doctors to decide whether or not a biopsy is needed for these patients.
ISSN:1742-6588
1742-6596
DOI:10.1088/1742-6596/1751/1/012041